Use of BAFF to treat sepsis

Details for Australian Patent Application No. 2005295713 (hide)

Owner The Washington University

Inventors Hotchkiss, Richard S.

Agent Cullens

Pub. Number AU-B-2005295713

PCT Pub. Number WO2006/044582

Priority 60/618,438 13.10.04 US

Filing date 13 October 2005

Wipo publication date 27 April 2006

Acceptance publication date 16 June 2011

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

17 May 2007 PCT application entered the National Phase

  PCT publication WO2006/044582 Priority application(s): WO2006/044582

16 June 2011 Application Accepted

  Published as AU-B-2005295713

13 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005295715-Fully enclosed carton

2005295708-Pharmaceutical compositions comprising a toxin-binding oligosaccharide and a polymeric particle